Autolus Therapeutics AUTL
NASDAQ AUTL
$1.93 +0.07 (+3.76%)
As of: Sep 30, 2026 · 3:25 PM EDT

Autolus Therapeutics (AUTL) Debt Ratio (2017 - 2019)

Updated

Autolus Therapeutics' Debt Ratio was 0.00 in Q4 2019, down 72.7% from the prior quarter.

Analysis

Autolus Therapeutics (AUTL) Debt Ratio (2017 - 2019) Analysis & Trends

From Q4 2017 onward, Autolus Therapeutics has reported Debt Ratio for 4 quarters.

  • In earlier years, Debt Ratio was 0.00 in FY2018 and 0.01 in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 0.24
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 0.52
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 0.42
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 0.31
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 0.00
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 0.60
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 0.53
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Autolus Therapeutics 660.38 Mn -663.71 Mn 25.22 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 0.00
Jun 30, 2019 0.00
Dec 31, 2018 0.00
Sep 30, 2018 0.00
Sep 30, 2017 0.01
API Access

Autolus Therapeutics Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=AUTL&period=max&api_key=YOUR_API_KEY